Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Dec 28, 2015; 7(30): 2933-2939
Published online Dec 28, 2015. doi: 10.4254/wjh.v7.i30.2933
Published online Dec 28, 2015. doi: 10.4254/wjh.v7.i30.2933
Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma
Masanori Matsuda, First Department of Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan
Author contributions: Matsuda M solely contributed to this work.
Conflict-of-interest statement: The author has no conflict of interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Masanori Matsuda, MD, PhD, First Department of Surgery, Yamanashi University School of Medicine, 1110 Shimokato, Chuo-city, Yamanashi 409-3898, Japan. masam@yamanashi.ac.jp
Telephone: +81-55-2737390 Fax: +81-55-2737390
Received: May 24, 2015
Peer-review started: May 25, 2015
First decision: August 16, 2015
Revised: October 7, 2015
Accepted: December 1, 2015
Article in press: December 2, 2015
Published online: December 28, 2015
Peer-review started: May 25, 2015
First decision: August 16, 2015
Revised: October 7, 2015
Accepted: December 1, 2015
Article in press: December 2, 2015
Published online: December 28, 2015
Core Tip
Core tip: Gadoxetic acid- or gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging has excellent lesion detection and characterization for both hypervascular hepatocellular carcinomas (HCC) in arterial phase imaging and hypovascular early HCC in hepatobiliary phase imaging, and has become an indispensable imaging modality in the treatment of HCC. Early HCC is known to progress to conventional hypervascular HCC. Although early HCC itself is currently not considered to be a target lesion for hepatic resection, if concomitant early HCC with progressed HCC is at high risk of hypervascularization, its simultaneous treatment at the time of hepatic resection is recommended.